4880
M. Sannigrahi et al. / Tetrahedron Letters 47 (2006) 4877–4880
2. Orjales, A.; Mosquera, R.; Toledo, A.; Pumar, C.;
stirred for 1.5 h. Satd NH4Cl (3.5 mL) was added at
(À78 °C) and the reaction mixture allowed to warm up to
room temperature. The reaction mixture was extracted
with CH2Cl2. The organic layer was dried over MgSO4,
filtered, concentrated and purified over silica gel using 0–
20% ethyl acetate in CH2Cl2 to yield 17a (R) and 17a (S).
Either the crude diastereomeric mixture of 17 or the
separated isomers 17a (R) or 17a (S) could be used in the
next step. To a solution of 17a (1.0 mmol) in CH3CN
(9.0 mL) and glacial acetic acid (3 mL) was added NaC-
NBH3 (3.0 mmol) and the reaction mixture was heated at
55 °C for 12 h, cooled to RT, evaporated to dryness and
redissolved in CH2Cl2. The organic layer was washed with
1N NaOH, brine and filtered through Na2SO4, concen-
trated and purified over silica gel using 50% EtOAc in
hexanes to yield 18a. Spectral data were obtained for all
new compounds. Analytical and 1H NMR data for some
representative compounds are included below. Compound
17a (S) (major isomer): mp 147–150 °C. MS (ES) calcd for
C18H32N2O3 (M+H)+ 324.2, found 324.2; 1H NMR
(400 MHz, CD3OD): d ppm: 0.94 (s, 9H); 0.95 (s, 3H);
0.96 (s, 3H); 1.04 (s, 9H); 1.58 (m, 1H); 1.98 (m, 1H); 2.19
(m, 2H); 3.25 (m, 2H); 3.78 (m, 1H); 5.02 (m, 1H).
Compound 17a (R) (minor isomer): mp 132–136 °C. MS
(ES) calcd for C18H32N2O3 (M+H)+ 324.2, found 324.2;
1H NMR (400 MHz, CD3OD): d ppm: 0.95 (s, 12H); 1.04
(s, 3H); 1.38 (s, 9H); 1.6 (m, 1H); 1.98 (m, 1H); 2.20 (m,
2H); 3.39 (m, 1H); 3.70 (m, 1H); 4.05 (m, 1H); 5.02 (m,
1H). Compound 18a: mp 116–118 °C. MS (ES) calcd for
C18H34N2O3 (M+H)+ 327.2, found 327.2; 1H NMR
(400 MHz, CDCl3): d ppm: 0.97 (s, 12H); 1.38 (s, 9H);
1.57 (s, 3H); 2.14 (s, 2H); 2.62 (m, 1H); 3.15 (m, 1H); 3.51
(m, 1H); 3.71 (9m, 1H); 4.30 (t, 1H, J = 12.8 Hz); 4.71 (d,
1H, J = 10.2 Hz).
Labeaga, L.; Innerarity, A. Eur. J. Med. Chem. 2002, 37,
721–730.
3. Toyooka, N.; Nemoto, H. In Studies in Natural Products
Chemistry; Bioactive Natural Products (Part J); Elsevier:
Oxford, 2003; Vol. 29, pp 419–448.
4. Milewska, M.; Bytner, T.; Polonski, T. Synthesis 1996,
1485–1488.
5. (a) Sheehan, J. C.; Tulis, R. W. J. Org. Chem. 1974, 39,
2264–2267; (b) Moehrle, H.; Jeandree, M.; Breitmaier, E.;
Rohonczy, J. J. Prakt. Chem. 2000, 342, 473–485.
6. (a) Williams, P. D.; Perlow, D. S.; Payne, L. S.; Holloway,
M. K.; Peter, S. K. J. Med. Chem. 1991, 38, 887–900; (b)
Butler, D. E.; Nordin, I. C.; L’Italien, Y. J.; Zweisler, L.;
Poschel, P. H.; Marriot, J. G. J. Med. Chem. 1984, 27, 684–
691; (c) Scott, M. K.; Baxter, E. W.; Bennett, D. J.; Boyd,
R. E.; Blum, P. S. J. Med. Chem. 1995, 38, 4198–4210.
7. Dias, L. C.; Fernandes, A. M. A. P.; Zukerman-Schpec-
tor, J. Syn. Lett. 2002, 1, 100–104.
8. (a) Deprez, P.; Royer, J.; Husson, H.-R. Tetrahedron 1993,
49, 3781–3792; (b) Adam, D. J.; Blake, A. J.; Cooke, P. A.;
Gill, C. D.; Simpkins, N. S. Tetrahedron 2002, 58, 4603–
4615.
9. (a) Basha, A.; Orlando, J.; Weinreb, S. M. Synth.
Commun. 1977, 7, 549–552; (b) Auerbach, J.; McFord,
Z.; Weinreb, S. M. J. Org. Chem. 1976, 41, 725–726.
10. Vink, M. K. S.; Christien, A. S.; Mackova-Zabelinskaja,
M. F.; Pochlauer, P.; Castelijns, A. M. C. F.; Marseveen,
J. H. V.; Hiemstra, H.; Griengl, H.; Schoemaker, H. E.;
Rutjes, F. P. J. T. Adv. Synth. Catal. 2003, 345, 483–487.
11. Representative procedure to obtain 18: Superhydride
(2.2 mmol, 1 M soln in THF) was added to a cooled
(À78 °C) solution of the imide 16a (1.0 mmol) in anhy-
drous CH3CN (5.0 mL) and the reaction mixture was